Home > > > > Report Detail

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 07-Dec-2023
No. of pages: 106

Market Overview of Global Biosimilars market:

According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.

A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowable in biosimilar products.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biosimilars market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Biosimilars Market Report:

Market Size Estimates: Biosimilars market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Biosimilars market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Biosimilars market

Segment Market Analysis: Biosimilars market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Biosimilars market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Biosimilars Market: Revenue and sales volume of major countries in each region

Biosimilars Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Biosimilars market in major regions.

Biosimilars Industry Value Chain: Biosimilars market raw materials & suppliers, manufacturing process, distributors, downstream customers

Biosimilars Industry News, Policies & Regulations

Key players in the global Biosimilars market are covered in Chapter 12:

Pfizer Inc.

Samsung Bioepis

Mylan N.V

Sandoz International GmbH

Teva Pharmaceutical Industries Ltd.

Dr. Reddy's Laboratories Ltd.

Amgen Inc

F. Hoffmann-La Roche AG

Biocon

In Chapter 2 and Chapter 15.1, based on types, the Biosimilars market from 2018 to 2028 is primarily split into:

Human Growth Hormone

Erythropoietin

Monoclonal Antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Others

In Chapter 3 and Chapter 15.2, based on applications, the Biosimilars market from 2018 to 2028 covers:

Oncology

Blood Disorders

Growth Hormonal Deficiency

Chronic and Autoimmune Disorders

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Biosimilars market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Biosimilars Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Biosimilars Market Size (2018-2028)
1.3.1 Global Biosimilars Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Biosimilars Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Biosimilars Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Biosimilars Historic Revenue ($) by Type (2018-2023)
2.2 Global Biosimilars Historic Sales Volume by Type (2018-2023)
2.3 Human Growth Hormone Sales and Price (2018-2023)
2.4 Erythropoietin Sales and Price (2018-2023)
2.5 Monoclonal Antibodies Sales and Price (2018-2023)
2.6 Insulin Sales and Price (2018-2023)
2.7 Interferon Sales and Price (2018-2023)
2.8 Granulocyte-Colony Stimulating Factor Sales and Price (2018-2023)
2.9 Others Sales and Price (2018-2023)

3 Global Biosimilars Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Biosimilars Historic Revenue ($) by Application (2018-2023)
3.2 Global Biosimilars Historic Sales Volume by Application (2018-2023)
3.3 Oncology Sales, Revenue and Growth Rate (2018-2023)
3.4 Blood Disorders Sales, Revenue and Growth Rate (2018-2023)
3.5 Growth Hormonal Deficiency Sales, Revenue and Growth Rate (2018-2023)
3.6 Chronic and Autoimmune Disorders Sales, Revenue and Growth Rate (2018-2023)
3.7 Others Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Biosimilars Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Biosimilars Industry News
4.7.2 Biosimilars Industry Policies

5 Global Biosimilars Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Biosimilars Sales Volume by Region (2018-2023)
5.2 Global Biosimilars Market Revenue ($) by Region (2018-2023)

6 Global Biosimilars Import Volume and Export Volume by Major Regions
6.1 Global Biosimilars Import Volume by Region (2018-2023)
6.2 Global Biosimilars Export Volume by Region (2018-2023)

7 North America Biosimilars Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Biosimilars Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Biosimilars Sales Volume and Growth Rate (2018-2023)
7.2 North America Biosimilars Market Trends Analysis Under Global Inflation
7.3 North America Biosimilars Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Biosimilars Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Biosimilars Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Biosimilars Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Biosimilars Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Biosimilars Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Biosimilars Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Biosimilars Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Biosimilars Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Biosimilars Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Biosimilars Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Biosimilars Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Biosimilars Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Biosimilars Revenue ($) and Growth Rate (2018-2023)

9 Europe Biosimilars Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Biosimilars Sales Volume and Growth Rate (2018-2023)
9.2 Europe Biosimilars Market Trends Analysis Under Global Inflation
9.3 Europe Biosimilars Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Biosimilars Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Biosimilars Revenue ($) and Growth Rate (2018-2023)

10 Latin America Biosimilars Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Biosimilars Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Biosimilars Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Biosimilars Market Trends Analysis Under Global Inflation
10.3 Latin America Biosimilars Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Biosimilars Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Biosimilars Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Biosimilars Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Biosimilars Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Biosimilars Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Biosimilars Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Biosimilars Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Biosimilars Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Biosimilars Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Biosimilars Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Biosimilars Revenue ($) and Market Share of Key Players
12.1.2 Global Biosimilars Sales Volume and Market Share of Key Players
12.1.3 Global Biosimilars Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Pfizer Inc. Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Pfizer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Samsung Bioepis Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Samsung Bioepis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Mylan N.V Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Mylan N.V Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Sandoz International GmbH Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Sandoz International GmbH Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Teva Pharmaceutical Industries Ltd. Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Teva Pharmaceutical Industries Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Dr. Reddy's Laboratories Ltd. Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Dr. Reddy's Laboratories Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Amgen Inc Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Amgen Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 F. Hoffmann-La Roche AG Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 F. Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Biocon Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Biocon Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Biosimilars Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Biosimilars
13.3.3 Raw Material Cost of Biosimilars
13.3.4 Labor Cost of Biosimilars
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Biosimilars Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Biosimilars Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Biosimilars Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Biosimilars Sales Volume Forecast by Type (2023-2028)
15.2 Global Biosimilars Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Biosimilars Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Biosimilars Sales Volume Forecast by Application (2023-2028)
15.3 Global Biosimilars Sales Volume Forecast by Region (2023-2028)
15.4 Global Biosimilars Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Biosimilars Picture
Table Biosimilars Definition
Table Description and Definitions
Figure Human Growth Hormone Features
Figure Erythropoietin Features
Figure Monoclonal Antibodies Features
Figure Insulin Features
Figure Interferon Features
Figure Granulocyte-Colony Stimulating Factor Features
Figure Others Features
Table Description and Definitions
Figure Oncology
Figure Blood Disorders
Figure Growth Hormonal Deficiency
Figure Chronic and Autoimmune Disorders
Figure Others
Figure North America Biosimilars Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Biosimilars Revenue ($) and Growth Rate (2018-2028)
Figure Europe Biosimilars Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Biosimilars Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Biosimilars Revenue ($) and Growth Rate (2018-2028)
Figure Global Biosimilars Revenue ($) and Growth Rate (2018-2028)
Figure Global Biosimilars Sales Volume and Growth Rate (2018-2028)
Table Global Biosimilars Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Biosimilars Historic Revenue ($) Share by Type (2018-2023)
Table Global Biosimilars Historic Sales Volume by Type (2018-2023)
Table Global Biosimilars Historic Sales Volume Share by Type (2018-2023)
Figure Global Human Growth Hormone Sales and Growth Rate (2018-2023)
Figure Global Human Growth Hormone Price (2018-2023)
Figure Global Erythropoietin Sales and Growth Rate (2018-2023)
Figure Global Erythropoietin Price (2018-2023)
Figure Global Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Global Monoclonal Antibodies Price (2018-2023)
Figure Global Insulin Sales and Growth Rate (2018-2023)
Figure Global Insulin Price (2018-2023)
Figure Global Interferon Sales and Growth Rate (2018-2023)
Figure Global Interferon Price (2018-2023)
Figure Global Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2018-2023)
Figure Global Granulocyte-Colony Stimulating Factor Price (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Price (2018-2023)
Table Global Biosimilars Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Biosimilars Historic Revenue ($) Share by Application (2018-2023)
Table Global Biosimilars Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Biosimilars Historic Sales Volume Share by Application (2018-2023)
Figure Global Oncology Sales and Growth Rate (2018-2023)
Figure Global Oncology Revenue and Growth Rate (2018-2023)
Figure Global Blood Disorders Sales and Growth Rate (2018-2023)
Figure Global Blood Disorders Revenue and Growth Rate (2018-2023)
Figure Global Growth Hormonal Deficiency Sales and Growth Rate (2018-2023)
Figure Global Growth Hormonal Deficiency Revenue and Growth Rate (2018-2023)
Figure Global Chronic and Autoimmune Disorders Sales and Growth Rate (2018-2023)
Figure Global Chronic and Autoimmune Disorders Revenue and Growth Rate (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Biosimilars Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Biosimilars Sales Volume by Region (2018-2023)
Table Global Biosimilars Sales Volume Share by Region (2018-2023)
Table Global Biosimilars Market Revenue ($) by Region (2018-2023)
Table Global Biosimilars Market Revenue ($) Share by Region (2018-2023)
Table Global Biosimilars Import Volume by Region (2018-2023)
Table Global Biosimilars Export Volume by Region (2018-2023)
Figure North America Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure North America Biosimilars Sales Volume and Growth Rate (2018-2023)
Table North America Biosimilars Market Trends Analysis Under Global Inflation
Table North America Biosimilars Revenue ($) by Country (2018-2023)
Table North America Biosimilars Sales Volume by Country (2018-2023)
Figure United States Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Canada Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Biosimilars Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Biosimilars Market Trends Analysis Under Global Inflation
Table Asia Pacific Biosimilars Revenue ($) by Country (2018-2023)
Table Asia Pacific Biosimilars Sales Volume by Country (2018-2023)
Figure China Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Japan Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure India Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Biosimilars Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Biosimilars Revenue ($) by Country (2018-2023)
Figure Australia Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Europe Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Europe Biosimilars Sales Volume and Growth Rate (2018-2023)
Table Europe Biosimilars Market Trends Analysis Under Global Inflation
Table Europe Biosimilars Revenue ($) by Country (2018-2023)
Table Europe Biosimilars Sales Volume by Country (2018-2023)
Figure Germany Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure France Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Italy Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Spain Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Russia Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Poland Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Biosimilars Sales Volume and Growth Rate (2018-2023)
Table Latin America Biosimilars Market Trends Analysis Under Global Inflation
Table Latin America Biosimilars Revenue ($) by Country (2018-2023)
Table Latin America Biosimilars Sales Volume by Country (2018-2023)
Figure Mexico Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Biosimilars Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Biosimilars Market Trends Analysis Under Global Inflation
Table Middle East and Africa Biosimilars Revenue ($) by Country (2018-2023)
Table Middle East and Africa Biosimilars Sales Volume by Country (2018-2023)
Figure GCC Countries Biosimilars Revenue ($) and Growth Rate (2018-2023)
Figure Africa Biosimilars Revenue ($) and Growth Rate (2018-2023)
Table Global Biosimilars Revenue ($) of Key Players (2018-2023)
Table Global Biosimilars Revenue ($) Share of Key Players (2018-2023)
Table Global Biosimilars Sales Volume of Key Players (2018-2023)
Table Global Biosimilars Sales Volume Share of Key Players (2018-2023)
Table Global Biosimilars Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table Pfizer Inc. Company Profiles
Table Product Profiles and Application
Table Pfizer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2018-2023
Table Samsung Bioepis Company Profiles
Table Product Profiles and Application
Table Samsung Bioepis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Samsung Bioepis Production and Growth Rate
Figure Samsung Bioepis Value ($) Market Share 2018-2023
Table Mylan N.V Company Profiles
Table Product Profiles and Application
Table Mylan N.V Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Mylan N.V Production and Growth Rate
Figure Mylan N.V Value ($) Market Share 2018-2023
Table Sandoz International GmbH Company Profiles
Table Product Profiles and Application
Table Sandoz International GmbH Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sandoz International GmbH Production and Growth Rate
Figure Sandoz International GmbH Value ($) Market Share 2018-2023
Table Teva Pharmaceutical Industries Ltd. Company Profiles
Table Product Profiles and Application
Table Teva Pharmaceutical Industries Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2018-2023
Table Dr. Reddy's Laboratories Ltd. Company Profiles
Table Product Profiles and Application
Table Dr. Reddy's Laboratories Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Dr. Reddy's Laboratories Ltd. Production and Growth Rate
Figure Dr. Reddy's Laboratories Ltd. Value ($) Market Share 2018-2023
Table Amgen Inc Company Profiles
Table Product Profiles and Application
Table Amgen Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Amgen Inc Production and Growth Rate
Figure Amgen Inc Value ($) Market Share 2018-2023
Table F. Hoffmann-La Roche AG Company Profiles
Table Product Profiles and Application
Table F. Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure F. Hoffmann-La Roche AG Production and Growth Rate
Figure F. Hoffmann-La Roche AG Value ($) Market Share 2018-2023
Table Biocon Company Profiles
Table Product Profiles and Application
Table Biocon Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Biosimilars
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Biosimilars with Contact Information
Figure Production Process of Biosimilars
Figure Manufacturing Cost Structure of Biosimilars
Table Major Distributors of Biosimilars with Contact Information
Table Major Downstream Buyers of Biosimilars with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Biosimilars Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Biosimilars Revenue ($) Share Forecast by Type (2023-2028)
Table Global Biosimilars Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Biosimilars Sales Volume Share Forecast by Type (2023-2028)
Table Global Biosimilars Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Biosimilars Revenue ($) Share Forecast by Application (2023-2028)
Table Global Biosimilars Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Biosimilars Sales Volume Share Forecast by Application (2023-2028)
Table Global Biosimilars Sales Volume Forecast by Region (2023-2028)
Table Global Biosimilars Sales Volume Share Forecast by Region (2023-2028)
Table Global Biosimilars Revenue ($) Forecast by Region (2023-2028)
Table Global Biosimilars Revenue ($) Share Forecast by Region (2023-2028)
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs